• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用组织型纤溶酶原激活剂治疗脑室内出血。

Treatment of intraventricular hemorrhage with tissue plasminogen activator.

作者信息

Findlay J M, Grace M G, Weir B K

机构信息

Division of Neurosurgery, University of Alberta, Edmonton, Canada.

出版信息

Neurosurgery. 1993 Jun;32(6):941-7; discussion 947. doi: 10.1227/00006123-199306000-00010.

DOI:10.1227/00006123-199306000-00010
PMID:8327096
Abstract

The patients with intraventricular hemorrhage (IVH) were treated with recombinant tissue plasminogen activator (rt-PA) injected directly into the lateral ventricles, followed by ventricular drainage. All had a decreased level of consciousness before treatment (Glasgow Coma Scale score 10 +/- 3.4). A total dose between 2 and 12 mg of rt-PA (6.4 +/- 3.3) was administered. For eight patients with aneurysmal IVH, treatment with rt-PA began with two patients the same day as the aneurysm clipping, and the day after with six patients. For a patient with an excision of a ruptured arteriovenous malformation and a patient with IVH resulting from a lateral ventricular catheterization during posterior fossa tumor surgery, treatment with rt-PA started 24 hours after surgery. After an injection of rt-PA, the ventricular drain was closed for 1 hour, followed by alternate-hourly drainage and intracranial pressure (ICP) monitoring. Five patients received a second injection of rt-PA on the second postoperative day, and one patient received a third dose on the third day. Among the eight patients given rt-PA the day after surgery, the volume of external cerebrospinal fluid (CSF) drainage for 24 +/- 8 hours before treatment was 61 +/- 57 ml, and the mean ICP was 22 +/- 5 mm Hg during this same time. Younger age and poorer neurological condition correlated with higher ICP before treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

脑室内出血(IVH)患者接受重组组织型纤溶酶原激活剂(rt-PA)直接注入侧脑室治疗,随后进行脑室引流。所有患者治疗前意识水平均下降(格拉斯哥昏迷量表评分为10±3.4)。rt-PA的总剂量为2至12毫克(6.4±3.3)。对于8例动脉瘤性IVH患者,2例在动脉瘤夹闭当天开始用rt-PA治疗,6例在次日开始治疗。对于1例破裂动静脉畸形切除术患者和1例后颅窝肿瘤手术期间因侧脑室置管导致IVH的患者,术后24小时开始用rt-PA治疗。注射rt-PA后,脑室引流管关闭1小时,随后每小时交替引流并监测颅内压(ICP)。5例患者在术后第二天接受了第二次rt-PA注射,1例患者在第三天接受了第三次注射。在术后第二天接受rt-PA治疗的8例患者中,治疗前24±8小时的外部脑脊液(CSF)引流量为61±57毫升,同一时间平均ICP为22±5毫米汞柱。年龄较小和神经功能较差与治疗前较高的ICP相关。(摘要截短至250字)

相似文献

1
Treatment of intraventricular hemorrhage with tissue plasminogen activator.用组织型纤溶酶原激活剂治疗脑室内出血。
Neurosurgery. 1993 Jun;32(6):941-7; discussion 947. doi: 10.1227/00006123-199306000-00010.
2
Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.重组组织型纤溶酶原激活剂治疗动脉瘤性脑室内出血的队列研究
Neurosurgery. 2004 Sep;55(3):532-7; discussion 537-8. doi: 10.1227/01.neu.0000134473.98192.b1.
3
Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage.重组组织型纤溶酶原激活剂治疗重症脑室内出血对血凝块溶解及脑室扩张的影响
Acta Neurochir (Wien). 1993;122(1-2):32-8. doi: 10.1007/BF01446983.
4
Recombinant tissue plasminogen activator in the treatment of intraventricular hemorrhage secondary to periventricular arteriovenous malformation before surgery: case report.重组组织型纤溶酶原激活剂在术前治疗脑室周围动静脉畸形继发脑室内出血中的应用:病例报告
Neurosurgery. 2003 Apr;52(4):964-8; discussion 968-9. doi: 10.1227/01.neu.0000053028.06474.c6.
5
Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage.重组组织型纤溶酶原激活剂治疗成人自发性脑室内出血。
Surg Neurol. 1998 Dec;50(6):526-31; discussion 531-2. doi: 10.1016/s0090-3019(97)00504-1.
6
Intraventricular administration of rt-PA in patients with intraventricular hemorrhage.脑室内出血患者脑室内给予重组组织型纤溶酶原激活剂(rt-PA)。
South Med J. 2005 Aug;98(8):767-73. doi: 10.1097/01.smj.0000170732.24324.ea.
7
Safety of intraventricular hemorrhage (IVH) thrombolysis based on CT localization of external ventricular drain (EVD) fenestrations and analysis of EVD tract hemorrhage.基于 CT 定位脑室外引流(EVD)管窗和 EVD 管腔出血分析的脑室内出血(IVH)溶栓安全性。
Neurocrit Care. 2013 Aug;19(1):103-10. doi: 10.1007/s12028-012-9713-1.
8
Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling.血管内动脉瘤栓塞术后脑室内出血的溶栓治疗。
Neurocrit Care. 2005;3(2):153-6. doi: 10.1385/NCC:3:2:153.
9
Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage.脑室内注射重组组织型纤溶酶原激活剂用于溶解脑室内出血。
J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):447-51. doi: 10.1136/jnnp.58.4.447.
10
Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.采用声溶栓微创清除自发性脑出血。
J Neurosurg. 2011 Sep;115(3):592-601. doi: 10.3171/2011.5.JNS10505. Epub 2011 Jun 10.

引用本文的文献

1
Phenomenon of Hematocephalus: A Comprehensive Review of the Literature.头颅积血现象:文献综述
JMA J. 2023 Apr 14;6(2):120-127. doi: 10.31662/jmaj.2022-0202. Epub 2023 Mar 13.
2
Endoscopic Evacuation of Massive Intraventricular Hemorrhages Reduces Shunt Dependency: A Meta-Analysis.内镜下清除大量脑室内出血可降低分流依赖:一项荟萃分析。
Asian J Neurosurg. 2022 Dec 5;17(4):541-546. doi: 10.1055/s-0042-1757220. eCollection 2022 Dec.
3
Direct Removal of Fourth Ventricle Hematoma in Massive Intraventricular Hemorrhage.大量脑室内出血时第四脑室血肿的直接清除术
J Korean Neurosurg Soc. 2022 Mar;65(2):325-330. doi: 10.3340/jkns.2021.0122. Epub 2021 Nov 30.
4
Adult Primary Intraventricular Hemorrhage: Clinical Characteristics and Outcomes.成人原发性脑室内出血:临床特征与预后
J Neurosci Rural Pract. 2020 Oct;11(4):623-628. doi: 10.1055/s-0040-1716770. Epub 2020 Sep 25.
5
Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.通过外部脑室引流管给药的组织型纤溶酶原激活剂的药代动力学和药效学
Neurocrit Care. 2015 Dec;23(3):386-93. doi: 10.1007/s12028-015-0126-9.
6
Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.蛛网膜下腔出血患者脑室内注射组织型纤溶酶原激活剂:一项前瞻性、随机、安慰剂对照的试点试验。
Neurocrit Care. 2014 Oct;21(2):275-84. doi: 10.1007/s12028-014-9965-z.
7
Intraventricular fibrinolysis for severe aneurysmal intraventricular hemorrhage: a randomized controlled trial and meta-analysis.脑室纤维蛋白溶解治疗严重脑室内出血:一项随机对照试验和荟萃分析。
Neurosurg Rev. 2013 Oct;36(4):523-30; discussion 530-1. doi: 10.1007/s10143-013-0469-7. Epub 2013 May 2.
8
Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group.脑室重组组织型纤溶酶原激活剂治疗脑室内出血后全身血液学状态:CLEAR IVH 研究组。
Stroke. 2011 Dec;42(12):3631-3. doi: 10.1161/STROKEAHA.111.625749. Epub 2011 Sep 22.
9
Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage.双导管与单导管在严重脑室出血中的引流效率比较。
Neurocrit Care. 2012 Jun;16(3):399-405. doi: 10.1007/s12028-011-9569-9.
10
Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report.脑室内出血继发于脑室内动脉瘤破裂——动静脉畸形栓塞后成功治疗:病例报告。
Neurosurgery. 2011 Feb;68(2):E581-6; discussion E586. doi: 10.1227/NEU.0b013e31820208a6.